Form 10-SB Filed by MediQuik Services Inc.; New NASD Rules Require `Full Disclosure' SEC Filing to Maintain Quotation on OTC Bulletin Board

Business Wire, Sept 2, 1999

HOUSTON--(BUSINESS WIRE)--Sept. 2, 1999--

MediQuik Services Inc. (OTC BB:MDQK) announced today that it filed a Form 10-SB registration statement with the U.S. Securities and Exchange Commission (SEC) on Aug. 24, 1999. The financial disclosure for MediQuik is publicly available via the SEC web site at http://www.sec.gov by searching the EDGAR database. Pursuant to the filing of the registration statement, Deloitte & Touche LLP (D&T) completed its audit of MediQuik with no qualifications. The Form 10-SB is currently under review by the SEC and must clear comments to become effective.

On Jan. 4, 1999, the SEC ratified amendments to NASD Rules 6530 and 6540 restricting OTC Bulletin Board (OTCBB) listing and quotation to securities of those companies that report current financial information to the SEC, insurance or banking regulation authorities. For MediQuik to comply with the new NASD eligibility requirements, the Form 10-SB must become effective and the SEC must come to a position of no further comment on the filing. The new NASD eligibility rules and implementation schedule are available for public review via the OTC Bulletin Board web site at http://www.otcbb.com.

"The completion of our audit by Deloitte & Touche and the filing of the Form 10-SB represents a significant public markets event for MediQuik," says Grant Gables, President. "Full reporting status is very important as we move beyond a development stage company to achieve meaningful financial results. As a publicly traded company, MediQuik is fully committed to providing our shareholder's with detailed, audited financial information in compliance with SEC regulations."

Form 10-SB is a registration statement filed under the Securities Exchange Act of 1934. Once effective, MediQuik will file quarterly and annual disclosure statements to the SEC.

MediQuik is a growing chronic disease management company providing significant cost savings to managed care organizations through supply and personal health management, patient education and compliance testing. By providing high-quality healthcare resources to the patient, MediQuik will reduce the cost of chronic disease while improving the wellness of the chronic disease patient.

This press release contains certain forward-looking statements within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934. Investors are cautioned that all statements included in this press release which concern the company and its operations, other than statements of historical fact, are forward-looking statements. Although the company believes that forward-looking statements contained herein are reasonable, they are based on numerous assumptions, any and all which could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included herein will be correct or accurate, the inclusion of such information should not be regarded as a representation by the Company or any other person that the objectives and plans of the Company will be achieved.